Evaluates anxiety and depression in RCPD patients, highlighting botulinum toxin's effectiveness as treatment.
Key Points
This study assesses the prevalence of anxiety and depression in patients with retrograde cricopharyngeus dysfunction and the efficacy of botulinum toxin treatment.
Conducted a questionnaire-based study on RCPD patients receiving cricopharyngeal botulinum toxin injections.
Participants completed anxiety and depression assessments (GAD-7, PHQ-9, ASQ) before, 6 weeks, and 6 months after treatment.
Analyzed changes in scores using ANOVA and established clinically significant improvements with minimal clinically important differences.
Seventy-seven RCPD patients completed the initial questionnaire, with 69 receiving treatment.
GAD-7 scores showed a significant decrease from 8.16 to 4.4 (p < 0.001) post-treatment.
PHQ-9 scores reduced from 7.87 to 4.20 (p = 0.002), indicating decreased depression levels.
64% of patients reported significant improvement in anxiety and 60% in depression after treatment.